Quick Asked: Urovant Sciences Contact Us?
Last update: 04 May, 2024 
357 Views
What is urovant sciences? Urovant Sciences is a clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapies for urologic conditions. Enzyvant Therapeutics is focused on transformative therapies for rare, often fatal, diseases.What is mymyovant sciences? Myovant Sciences is committed to addressing unmet need in women’s health and advanced prostate cancer through purpose-driven science, empowering medicines, and transformative advocacy. Urovant Sciences is a clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapies for urologic conditions.What is uvurovant sciences? Urovant Sciences. Improving quality of life through innovations in urology. Our lead product candidate, vibegron, is an investigational oral, once-daily, small molecule beta-3 agonist, being developed for overactive bladder (OAB), OAB in men with benign prostatic hyperplasia (BPH) and pain associated with irritable bowel syndrome (IBS).Is mymyovant fda approved? Myovant is developing innovative medicines that hold promise to improve people’s lives. Now FDA Approved. You can learn more about MYFEMBREE by visiting the product website or downloading the full U.S. Prescribing Information including BOXED WARNING and Patient Information.
Listing Results Urovant Sciences Contact Us? Question Answers
News Releases Urovant Sciences
View Press Release. July 6, 2021. Urovant Sciences Named One of the 2021 Best Places to Work in Orange County. View Press Release. June 29, 2021. Urovant Sciences and Sunovion Pharmaceuticals Launch Primary Care Co-Promotion of GEMTESA® (vibegron) for Patients with Overactive Bladder. View Press Release. April 15, 2021.
Urovant Sciences, Inc in Boston, MA Company Info & Reviews
Urovant Sciences, Inc is a Massachusetts Foreign Corporation filed On June 16, 2020. The company's File Number is listed as 001442952. The Registered Agent on file for this company is Corporation Service Company and is located at 84 State Street, Boston, MA 02109.
Urovant Sciences, Inc. Careers Center Welcome
Welcome to the Careers Center for Urovant Sciences, Inc.. Please browse all of our available job and career opportunities. Apply to any positions you believe you are ...
Urovant’s New CEO Preps for Revenue Boost Orange County
Urovant has submitted the drug to the FDA, which has a set a deadline of Dec. 26 to approve the medication. “From that point on, we’ll be generating revenue,” Robinson said. Its second product candidate, URO-902, is a novel gene therapy that it is developing for patients with overactive bladder who have failed oral pharmacological therapy.
O’Melveny Represents Urovant in Its Sale to Sumitovant
O’Melveny Represents Urovant in Its Sale to Sumitovant November 17, 2020 FOR IMMEDIATE RELEASE. SILICON VALLEY—November 16, 2020—O’Melveny advised the special committee of Urovant Sciences’ board of directors in Urovant’s US$681 million definitive merger agreement with Sumitovant Biopharma. According to the terms of the deal, Sumitovant ...
INSTRUCTIONS FOR ENROLLMENT urovant.com
If you have questions about Urovant Patient Assistance Program or how to complete this form, please contact us at 866 -842 3476, 8am – 12am EST, Monday through Friday and 9am-5pm EST Sat- Sun MEDICATIONS AVAILABLE THROUGH THE ...
Urovant Sciences Starts Selling Drug for Overactive
Urovant Sciences of Irvine last week launched what it’s calling the first breakthrough medication for patients with overactive bladder in nearly a decade. The product, called Gemtesa, is expected to address “significant unmet needs” in a large and underpenetrated market of about 30 million patients in the U.S., Chief Executive Jim Robinson told the ...
Urovant Sciences, Inc. in Raleigh, NC Company Info & Reviews
Urovant Sciences, Inc. is a North Carolina Foreign Business Corporation filed On July 20, 2018. The company's filing status is listed as Current-Active and its File Number is 1729730. The Registered Agent on file for this company is Corporation Service Company and is located at 2626 Glenwood Ave Ste 550, Raleigh, NC 27608.
Requesting A GEMTESA® Representative
Phone. Preferred office visit. Virtual. In-person. By signing up, you certify that you are at least 18 years old and that you authorize GEMTESA and Urovant Sciences to send you information, products, special offers, and partner communications. Also, you may unsubscribe from marketing communications sent by email at any time by clicking on the
Urovant Sciences Crunchbase Company Profile & Funding
949-226-6029 Phone Number 949-226-6029 Urovant Sciences is a clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapies for urologic conditions.
Jobs with Urovant Sciences, Inc biospace.com
Urovant Sciences, Inc. today announced the appointment of Betzy Estrada as executive vice president and chief human resources officer. Urovant Sciences Named One of the 2021 Best Places to Work in Orange County . 7/6/2021. Urovant Sciences, a wholly owned subsidiary of Sumitovant, has been named as one of the 2021 Best Places to Work in Orange
Community Guidelines Urovant Sciences
Urovant Sciences is committed to creating innovative and responsive ways to support and educate the community. We have created a space online that is meant to be safe, informational and engaging for patients, healthcare providers, caregivers, employees, job ...
Urovant Sciences Overview, News & Competitors ...
(949) 226-6029 Urovant Sciences’s headquarters are in 5281 California Ave, Suite #100, Irvine, California, 92617, United States What is Urovant Sciences’s phone number? Urovant Sciences’s phone number is (949) 226-6029
Urovant Sciences Company Profile Office Locations
Urovant Sciences is a biopharmaceutical company focused on developing novel therapies for urologic conditions. The Company's lead therapeutic candidate is vibegron (RVT-901), an investigational oral β3-adrenergic agonist being developed for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and urinary frequency.
Privacy Policy Urovant Sciences
Generally, Urovant Sciences is the controller in relation to the collection and processing of personal information through the Services. If you have any questions or concerns about this Policy, you may contact us by e-mail at contactus@ urovant.com or write to us in care of: Urovant Sciences, Inc., 5281 California Ave., Suite 100, Irvine, CA 92617.
Urovant Sciences Provides Merger Update and Reports Third
In addition, securityholders of Urovant will be able to obtain free copies of the proxy statement and Schedule 13E-3 through the Investor Relations page of Urovant’s website, www.urovant.com, or by contacting Urovant’s Investor Relations Department by mail at Attention: Investor Relations, 5281 California Ave, Suite #100, Irvine, CA 92617
Urovant Sciences Jim Robinson Overactive Bladder Treatment
Urovant Sciences. Urovant.com. Media Contact: media@ urovant.com. Interview conducted by: Bud Wayne, Editorial Executive. CEOCFO Magazine Published – November 1, 2021. CEOCFO: Mr. Robinson, you were appointed president & CEO of Urovant Sciences, March 23, 2020, after having been a leader in multiple biopharmaceutical and ...
Investor Relations Urovant Sciences
Urovant Sciences is a biopharmaceutical company advancing urologic patient care through development of innovative therapies and exceptional licensing opportunities. Our goal is to be the leading specialty company, recognized and trusted by patients and providers for our commitment to urology and their well-being.
Home Urovant Sciences
Urovant Sciences is a biopharmaceutical company focused on developing and commercializing innovative therapies for urological conditions. Our goal is to be a leading specialty company, recognized and trusted by patients and providers for our commitment to urology. Urovant Sciences is driving scientific innovation to improve the quality of life
Urovant Sciences, Inc. Information Urovant Sciences, Inc
Urovant Sciences is a clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapies for urologic conditions. Urovant is a nimble company with an entrepreneurial focus on improving the way providers and their patients confront urologic diseases that are difficult to treat.
Urovant Sciences, Inc. in Salem, OR Company Info & Reviews
Urovant Sciences, Inc. is an Oregon Foreign Business Corporation filed On June 23, 2020. The company's filing status is listed as Active and its File Number is 1686667-91. The Registered Agent on file for this company is Corporation Service Company and is located at 1127 Broadway St Ne Ste 310, Salem, OR 97301.
Contact Urovant Sciences
Urovant Sciences, Inc. 5281 California Ave, Suite #100 Irvine, CA 92617 United States Urovant Sciences GmbH. Grosspeter Tower Grosspeteranlage 29 Basel 4052 Switzerland Suites 2006-2010 Email For general inquiries: contactus@ urovant.com For medical inquiries: medinfo@ urovant.com Help Line 1-833-UROVANT (876-8268)
Events and Presentations Urovant Sciences
The Investor Relations website contains information about Urovant Sciences's business for stockholders, potential investors, and financial analysts.
Sumitovant
Latest News. Sumitovant Biopharma Highlights Significant Clinical, Regulatory and Commercial Achievements Across its Portfolio of Companies in the Second Quarter of FY2021 December 10, 2021; Myovant Sciences to Host Second Fiscal Quarter 2021 Earnings Conference Call at 8:30 a.m. Eastern Time on October 26, 2021 October 12, 2021; Enzyvant Receives FDA Approval ...
Urovant Sciences Announces U.S. FDA Acceptance of New Drug
IRVINE, Calif. & BASEL, Switzerland--(BUSINESS WIRE)-- Urovant Sciences (Nasdaq: UROV) today announced that the U.S. Food and Drug Administration (FDA) has accepted for review the company’s New Drug Application (NDA) for once-daily 75 mg vibegron for the treatment of patients with overactive bladder (OAB) with symptoms of urge urinary ...
Urovant Sciences, Inc. in Salt Lake City, UT Company
Urovant Sciences, Inc. is an Utah Corporation - Foreign - Profit filed On August 10, 2020. The company's filing status is listed as Active and its File Number is 11892693-0143. The Registered Agent on file for this company is Corporation Service Company and is located at 15 West South Temple, Suite 600, Salt Lake City, UT 84101.